The impact of a dose of the angiotensin receptor blocker valsartan on post-myocardial infarction ventricular remodelling-Reference-Cited by-同舟云学术

The impact of a dose of the angiotensin receptor blocker valsartan on post-myocardial infarction ventricular remodelling

Published:2018-01-17 Issue:2 Volume:5 Page:354-363
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Park Kyungil¹,Kim Young-Dae¹,Kim Ki-Sik²,Lee Su-Hoon³,Park Tae-Ho¹,Lee Sang-Gon⁴,Kim Byung-Soo⁵,Hur Seung-Ho⁶,Yang Tae-Hyun⁷,Oh Joo-Hyun⁸,Hong Taek-Jong⁹,Park Jong-Sun¹⁰,Hwang Jin-Yong¹¹,Jeong Byungcheon¹²,Bae Woo-Hyung¹³,

Affiliation:

1. Division of Cardiology, Department of Internal Medicine; Dong-A University Hospital; Busan Republic of Korea

2. Division of Cardiology, Department of Internal Medicine; Catholic University of Daegu; Daegu Republic of Korea

3. Division of Cardiology, Department of Internal Medicine; Dongkang Medical Center; Ulsan Republic of Korea

4. Division of Cardiology, Department of Internal Medicine; Ulsan University Hospital; Ulsan Republic of Korea

5. Division of Cardiology, Department of Internal Medicine; Daedong Hospital; Busan Republic of Korea

6. Division of Cardiology, Department of Internal Medicine; Keimyung University Hospital; Daegu Republic of Korea

7. Division of Cardiology, Department of Internal Medicine; Inje University, Busan Paik Hospital; Busan Republic of Korea

8. Division of Cardiology, Department of Internal Medicine; Sungkyunkwan University, Samsung Changwon Hospital; Changwon Republic of Korea

9. Division of Cardiology, Department of Internal Medicine; Busan National University Hospital; Busan Republic of Korea

10. Division of Cardiology, Department of Internal Medicine; Yeungnam University Hospital; Daegu Republic of Korea

11. Division of Cardiology, Department of Internal Medicine; Gyeongsang University Hospital; Jinju Republic of Korea

12. Division of Cardiology; Daegu Fatima Hospital; Daegu Republic of Korea

13. Division of Cardiology; Bong Seong Memorial Hospital; Busan Republic of Korea

Funder

Novartis Korea

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials;Domanski;J Am Coll Cardiol,1999

2. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial;Pfeffer;N Engl J Med,1992

3. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure;The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators;Lancet,1993

4. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction;Kober;N Engl J Med,1995

5. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both;Pfeffer;N Engl J Med,2003

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Angiotensin Receptor Blocker Dose in Myocardial Infarction With Preserved Left Ventricular Systolic Function;Journal of Cardiovascular Pharmacology;2023-07

2. Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential;Nature Reviews Cardiology;2023-01-04

3. Prognostic impact of incident left ventricular systolic dysfunction after myocardial infarction;Frontiers in Cardiovascular Medicine;2022-09-29

4. Left Ventricular Remodeling after Myocardial Infarction: From Physiopathology to Treatment;Life;2022-07-24

5. Prognostic Impacts of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome Patients Without Heart Failure;Frontiers in Pharmacology;2022-04-05